Rotational thrombectomy describes a family of catheter-based systems that use a spinning or rotating element to break up thrombus so it can be aspirated or cleared from a deep vein. For clinicians managing deep vein thrombosis (DVT), understanding how these devices are engineered helps explain why they are chosen for certain clot burdens and vessel segments over other mechanical or pharmacomechanical options.
What Makes a Thrombectomy Device "Rotational"?
At the core of a rotational thrombectomy catheter is a rotating tip or shaft — often a leaf-tip, basket, or helical element — that macerates thrombus into smaller fragments as it advances through the occluded segment. This mechanical fragmentation is typically paired with an aspiration lumen so loosened clot material is withdrawn rather than left to travel downstream. The combination of fragmentation and continuous suction is what distinguishes rotational systems from purely aspiration-based catheters, which rely on vacuum alone to pull intact or semi-intact thrombus into the catheter.
Core Components: Drive Shaft, Tip, and Aspiration Lumen
The drive shaft transmits rotational force from an external motor or handle down to the catheter tip, and it is generally built from stainless steel or nitinol to balance flexibility with torque transmission through tortuous venous anatomy. The distal tip — commonly a leaf-tip or similarly shaped fragmentation element — is designed to engage thrombus while minimizing direct contact with the vessel wall. An integrated aspiration lumen runs alongside or through the shaft, allowing fragmented material to be evacuated during the same pass. Rotational speed is adjustable in many systems, letting the operator match fragmentation intensity to clot consistency, since fresh thrombus and more organized, chronic material respond differently to mechanical force.
How Does Rotational Speed Affect Clot Clearance?
Rotational speed in these systems is typically variable, spanning a wide range depending on the device and clinical scenario. Higher speeds can improve fragmentation of denser or more organized thrombus, while lower speeds may be preferred for fresher clot or when working near delicate structures. Because DVT can present anywhere along the acute-to-chronic spectrum, the ability to titrate rotational control — rather than operate at a single fixed speed — is one of the practical features clinicians weigh when comparing rotational platforms.
INVAMED's Rotational Thrombectomy Platform
INVAMED manufactures the Mantis PRO Rotational Thrombectomy and Ultra Aspiration system, a catheter-based device that combines a rotating leaf-tip design with an integrated aspiration lumen for deep venous and arterial occlusions. According to manufacturer-reported specifications, the system offers a rotational speed range in the tens of thousands of RPM and is built with a stainless steel or nitinol drive shaft paired with a flexible polymer outer sheath, along with adjustable rotational control intended to accommodate clots of varying consistency. More information is available on the Mantis PRO product page. A qualified physician determines whether a rotational thrombectomy device is appropriate for a given patient based on clot location, vessel size, and overall clinical picture.
Where Rotational Systems Fit Among Thrombectomy Options
Rotational devices are one branch of a broader mechanical thrombectomy category that also includes pure aspiration systems and pharmacomechanical devices that pair mechanical action with thrombolytic drugs. The choice between these approaches depends on factors such as clot age, vessel diameter, and whether the interventionalist wants to minimize or avoid thrombolytic drug exposure. None of these device categories is universally superior; each has situations where its design characteristics are more or less favorable, and treatment planning is individualized.
Can rotational thrombectomy be combined with clot-dissolving drugs?
Some rotational and related mechanical systems are designed with pharmacomechanical capability, meaning they can deliver or work alongside thrombolytic agents. Whether this combination is used depends on the specific device, the clot characteristics, and institutional protocols.
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.